Marie Skłodowska-Curie Innovative Training Network grant of 250,000 EUR to Roman Zubarev
Roman Zubarev has been funded within the Marie Skłodowska-Curie action “Innovative Training Networks”. The project aims to train a new generation of scientists in exploiting the concept of allostery in drug design.
The EU project ALLODD (allostery of drug design) will be coordinated from Athens, Greece. Karolinska Institutet is one of 12 organizations within the project. The total budget is 3.2 million EUR for 36 months.
The network aims to train a new generation of scientists in exploiting the concept of allostery in drug design. By putting together a whole array of technologies it aims to identify and characterize allosteric modulators of protein function that will be applied to therapeutically relevant systems.
“KI’s role will be to develop and share with other network participants novel methods of protein structural analysis by hydrogen-deuterium exchange mass spectrometry and chemical proteomics. These efforts will also be useful for SciLifeLab, where our Chemical proteomics facility is well appreciated”, says Roman Zubarev, Professor at the Department of Medical Biochemistry and Biophysics.
Marie Skłodowska-Curie action “Innovative Training Networks”
ITNs support competitively selected joint research training and/or doctoral programmes, implemented by European partnerships of universities, research institutions, and non-academic organisations.
The research training programmes provide experience outside academia, hence developing innovation and employability skills. ITNs include industrial doctorates, in which non-academic organisations have an equal role to universities in respect of the researcher's time and supervision, and joint doctoral degrees delivered by several universities. Furthermore, non-European organisations can participate as additional partners in ITNs, enabling doctoral-level candidates to gain experience outside Europe during their training.